Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -127.49% |
| Q3 2025 | 618.18% |
| Q2 2025 | 55.41% |
| Q1 2025 | -155.17% |
| Q4 2024 | 36.96% |
| Q3 2024 | -53.33% |
| Q2 2024 | 44.44% |
| Q1 2024 | 26.03% |
| Q4 2023 | 37.61% |
| Q3 2023 | -14.71% |
| Q2 2023 | 34.62% |
| Q1 2023 | -4.00% |
| Q4 2022 | 14.29% |
| Q3 2022 | -19.86% |
| Q2 2022 | -2.82% |
| Q1 2022 | 17.92% |
| Q4 2021 | 24.12% |
| Q3 2021 | 16.18% |
| Q2 2021 | -17.24% |
| Q1 2021 | -334.34% |
| Q4 2020 | 155.31% |
| Q3 2020 | -14.01% |
| Q2 2020 | 31.44% |
| Q1 2020 | -48.70% |
| Q4 2019 | -40.00% |
| Q3 2019 | 1.79% |
| Q2 2019 | -28.74% |
| Q1 2019 | -33.85% |
| Q4 2018 | -1.56% |
| Q3 2018 | -4.92% |
| Q2 2018 | -41.86% |
| Q1 2018 | -19.44% |
| Q4 2017 | -5.88% |
| Q3 2017 | 49.25% |
| Q2 2017 | -34.00% |
| Q1 2017 | -35.14% |
| Q4 2016 | 7.50% |
| Q3 2016 | -8.11% |
| Q2 2016 | 0.00% |
| Q1 2016 | 17.78% |